Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
Tweet
Share
E-mailGet Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics (NASDAQ: AARD) reported Q2 EPS of ($0.66), $0.21 better than the analyst estimate of ($0.87).
For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
